DGAP-News: Eureka Genomics and the James Hutton Institute Collaborate on a Novel Barley Genotyping Assay
(firmenpresse) - Eureka Genomics
11.01.2013 15:00
---------------------------------------------------------------------------
HERCULES, Calif., 2013-01-11 15:00 CET (GLOBE NEWSWIRE) --
Eureka Genomics is developing a custom assay for the genotyping of barley,
enabling identification of over 400 SNPs in a single test. At $15.00 per
sample, the assay will offer a low-cost opportunity for researchers to identify
and optimize traits such as yield, quality and environmental resilience for
commercial crop production.
Barley is the worlds 4th most important cereal and has significant worldwide
economic value for brewing and whisky distilling industries, animal feed and
FDA recognized potential for improving human health. By developing the barley
panel in conjunction with the James Hutton Institute (based in Scotland, UK),
Eureka Genomics will be positioned to introduce the assay both in Europe and in
the US next month. Details on the newly developed barley panel will be
available during the Plant and Animal Genome XXI Conference in San Diego,
California on January 13, 2013.
'The collaboration has resulted in a very cost-effective, medium-throughput
approach to single nucleotide polymorphism (SNP) genotyping, a fundamental
technology in both genetic studies and contemporary crop improvement programs
worldwide. As the Eureka technology offers the flexibility to increase both the
number of SNPs and samples per assay at low additional cost, we are already
focused on improving SNP representation and multiplex capability, further
reducing the cost per datapoint, a key requirement for widespread adoption in
commercial plant breeding,' said Robbie Waugh, Head of Genetics at the James
Hutton Institute.
The marker assay (LDMA) being offered by Eureka Genomics provides an improved
and economical alternative to traditional technologies for profiling hundreds
of SNPs (or other genetic markers) in thousands of samples using Next
Generation Sequencing (NGS). The assay can be broadly applied to the detection
of SNPs, CNV, presence/absence and methylation and is compatible with DNA or
RNA from virtually any organism, even when genome information may be
incomplete. 'The LDMA lets researchers design profiling panels that target the
markers that matter most for their project, rather than wasting time and
resources getting data that is irrelevant to their goals,' said Andrea White,
Director of Business Development for Eureka Genomics. 'The utility of the assay
has been demonstrated and validated at this point and we look forward to many
different research collaborations, such as we have developed with the James
Hutton Institute, to expand the testing services portfolio offered by Eureka
Genomics and address needs in plant, animal and clinical markets world-wide.'
About Eureka Genomics: Eureka Genomics (EG; www.eurekagenomics.com) is a leader
in advanced bioinformatics analysis of next-generation sequencing data, which
serves as the backbone of their low-density marker assays (LDMA). In addition,
EG leverages their analytical expertise to discover microorganisms associated
with cancers and other life threatening diseases and the development of related
molecular diagnostics. EG uses proprietary algorithms and biological
problem-solving expertise to provide collaborative and cost-effective high
quality sequencing and analysis services to a broad range of university,
government and industry researchers worldwide. For more information, please
contact Didier Perez, 415 269 0666. didier(at)eurekagenomics.com. Visit us at PAG
XXI San Diego, CA at Booth 206.
About The James Hutton Institute: The James Hutton Institute is a brand new
international research Centre based in Scotland. The work we do is right at the
top of the global agenda and involves tackling some of the world's most
challenging problems including the impact of climate change and threats to food
and water security. The James Hutton Institute brings together the Macaulay
Land Use Research Institute and SCRI (Scottish Cro Research Institute) both of
which have illustrious histories. The new institute was created on 1 April
2011. For more information, please contact: info(at)hutton.ac.uk
News Source: NASDAQ OMX
11.01.2013 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Eureka Genomics
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US9902094476
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.01.2013 - 15:00 Uhr
Sprache: Deutsch
News-ID 218761
Anzahl Zeichen: 6416
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 173 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Eureka Genomics and the James Hutton Institute Collaborate on a Novel Barley Genotyping Assay"
steht unter der journalistisch-redaktionellen Verantwortung von
Eureka Genomics (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
